According to Eurofins Scientific's latest financial reports the company has $1.35 B in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-12-31 | $1.35 B | 159.08% |
2022-12-31 | $0.52 B | -10.7% |
2021-12-31 | $0.58 B | -48% |
2020-12-31 | $1.12 B | 237.31% |
2019-12-31 | $0.33 B | -42.55% |
2018-12-31 | $0.57 B | -41.2% |
2017-12-31 | $0.98 B | 13.25% |
2016-12-31 | $0.86 B | 0.2% |
2015-12-31 | $0.86 B | 229.43% |
2014-12-31 | $0.26 B | -35.82% |
2013-12-31 | $0.41 B | 131.12% |
2012-12-31 | $0.17 B | -23.64% |
2011-12-31 | $0.23 B | 62.68% |
2010-12-31 | $0.14 B | 83.6% |
2009-12-31 | $77.88 M | -57.69% |
2008-12-31 | $0.18 B | 94.63% |
2007-12-31 | $94.57 M | -10.96% |
2006-12-31 | $0.10 B | 117.95% |
2005-12-31 | $48.73 M | -0.74% |
2004-12-31 | $49.09 M |